Iron
Pregnancy Disorder
Swiss Federal Institute of TechnologySmall moleculeN/ADormant
D
30/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 15/ 100
- Competitive Position
- 95/ 100
Competitive context
5 Active assets in the Pregnancy Disorder cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Cefazolin MemorialCare Health System | Phase 4 | BBB |
Metformin Norwegian University of Science and Technology | Phase 4 | BBB |
ROPIVACAINE Northwestern University | Phase 4 | BB |
Folic Acid University Magna Graecia | Phase 4 | BB |
CLOMIPHENE CITRATE Yale University | Phase 3 | BB |
View all 23 →
Same molecule, other indications
Iron is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →